Global Clinical Trial Packaging Market

Clinical Trial Packaging Market Size, Share, Growth Analysis, By Clinical trial type(Therapeutic & Prevention and Diagnostics), By Packaging Type(Syringes, Vials & Ampoules, Blisters, Tubes), By Material(Plastic, Glass, Metal, Paper and Corrugated Fiber), By End User(Research Laboratories, Clinical Research Organizations, Drug Manufacturing Facilities), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35B2071 | Region: Global | Published Date: July, 2024
Pages: 242 | Tables: 121 | Figures: 77

Clinical Trial Packaging Market News

  • In October 2022, leading provider of clinical trial supplies Myonex has completed the purchase of Berlin, Germany-based Hubertus Apotheke's clinical trial and packaging operations. The newly formed firm, Myonex GmbH, improves the company's footprint within the European Union and supports its recent expansion.
  • In July 2022 Sharp, a global provider of contract packaging and clinical supply services, has partnered with ClinsChain, a company with operations in China, to increase its presence and capabilities there. To help Sharp's pharma and biopharma clients gain access to the Chinese market while also assisting Chinese innovators in expanding their global footprint, Sharp will work with ClinsChain, a company that specialises in providing clinical supply services for regional and international clinical trials.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Clinical Trial Packaging Market size was valued at USD 1079.09 million in 2019 and is poised to grow from USD 1169.76 million in 2023 to USD 2199.06 million by 2031, growing at a CAGR of 8.21% in the forecast period (2024-2031).

Global Clinical Trial Packaging Market is highly competitive and fragmented due to few major players. To increase their market share, the major companies in the international market are implementing a variety of business tactics, including mergers and acquisitions, expansions, and investments. Major players include Almac Group, Piramal Pharma Solutions, Clinical Supplies Management Holdings, Inc., Fisher Clinical Services, Inc. and others. These prominent players are focusing on R&D and new product development to stabilize their market share. 'Corden Pharma', ' Westrock Company ', ' Bilcare Limited ', ' Sharp Packaging Services ', ' Fisher Clinical Services ', ' PCI Pharma Services ', ' Almac Group ', ' Schreiner MediPharm ', ' Gerresheimer AG ', ' Mawdsleys Berlinger ', ' Stora Enso Oyj ', ' Thermo Fisher Scientific Inc. ', ' Wuxi Griffin Pharmaceutical Co., Ltd. ', ' WuXi AppTec ', ' Reed-Lane, Inc. ', ' Aphena Pharma Solutions ', ' Catalent, Inc. ', ' Berry Global, Inc. ', ' Nupharm Group ', ' Carton Service, Inc. '

Due to recent changes made to the methods utilised in pharmaceutical industry's research and development as well as the growing need for cutting-edge products and cures, it is projected that the global market will grow. The emergence of issues related to the use of plastic is also driving the demand for glass bottles. It is anticipated that the growth of the global clinical trial packaging market would be significantly impacted during the anticipated period by rising prevalence of infectious disorders

Aseptic blow-fill-seal (BFS) technology is a method for forming plastic containers, filling them with sterile, filtered product, and sealing them in a continuous sequence of steps inside a sterile, controlled environment on a single machine. The blow-fill-seal method is a reliable, cutting-edge aseptic processing technique that has gained the respect of regulatory bodies throughout the world for the inherent advantages it offers over traditional aseptic manufacturing. The versatility in packaging design, cheap operating costs, and high level of sterility assurance that come with blow-fill-seal systems is unmatched. The devices demand a minimal amount of operational workers and a small amount of space. Due to the growing emphasis on biologics, proteins, and other complicated solutions in recent years, blow-fill-seal technology has attracted a lot of market attention. These crucial goods frequently cannot endure prolonged contact to high temperatures without the active ingredients degrading.

North America dominated the Global Clinical Trial Packaging Market share and accounted for approximately 50% global revenue share in 2021. It is expected to continue its dominance during the forecast period. The pharmaceutical industry's success in North America is largely attributable to the region's abundance of clinical trials organisations and research labs. The pharmaceutical sector in North America is expected to develop at a rapid rate throughout the projected period due to a rise in R&D efforts. During the forecast period, the presence of stringent FDA rules for the packaging of goods and medications used in clinical trials is anticipated to drive regional clinical trials packaging market growth.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Clinical Trial Supplies Market
Buy Now GET FREE SAMPLE
Clinical Trial Materials And Supplies Market
Buy Now GET FREE SAMPLE
Medical Packaging Market
Buy Now GET FREE SAMPLE
Pharmaceutical Packaging Market
Buy Now GET FREE SAMPLE
Clinical Trials Market
Buy Now GET FREE SAMPLE
Sterile Medical Packaging Market
Buy Now GET FREE SAMPLE
E-Clinical Trials Solutions or Suite or Technologies Market
Buy Now GET FREE SAMPLE
Cosmetic Packaging Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Clinical Trial Packaging Market

Report ID: SQMIG35B2071

$5,300
BUY NOW GET FREE SAMPLE